Clinical Trials Logo

Clinical Trial Summary

Resistant starch (RS) is considered to have many of the same health benefits as dietary fiber. The aim of this study was to examine the effects of RS3 on postprandial glycemic and insulinemic responses and appetite. Healthy males (aged 18-35 years) participated in this study. Subjects were provided meals in the laboratory after overnight fasting on two separate occasions, at least 1 week apart. On each laboratory visit, subjects were given either a control meal (COM) or an RS3 meal (RSM). Both meals during the two visits consisted of vegetarian pasta and were matched for energy intake, composition, ingredients, and amount, but were prepared in different ways. The COM was hot, freshly cooked pasta, while the RSM was re-heated pasta that had been cooked the previous day and chilled overnight. Blood samples and subjective appetite ratings were collected at fasting and for a period of 3 h after meal consumption (i.e., 15-min intervals for glucose and 30-min intervals for insulin, ghrelin, and subjective appetite).


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05108142
Study type Interventional
Source King Saud University
Contact
Status Completed
Phase N/A
Start date November 1, 2019
Completion date March 15, 2020

See also
  Status Clinical Trial Phase
Completed NCT03689738 - Effects of Potato Resistant Starch Intake on Insulin Sensitivity, Related Metabolic Markers and Satiety N/A
Completed NCT05988580 - Postprandial Glycemia After Eating a Pasta Dish Made With Resistant Starch. N/A